780
Views
4
CrossRef citations to date
0
Altmetric
Review

Sensitization of (colon) cancer cells to death receptor related therapies

A report from the FP6-ONCODEATH research consortium

, , , , , , , , & show all
Pages 458-466 | Received 12 Oct 2011, Accepted 03 Feb 2012, Published online: 01 May 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ivana Manini, Andrea Sgorbissa, Harish Potu, Andrea Tomasella & Claudio Brancolini. (2013) The DeISGylase USP18 limits TRAIL-induced apoptosis through the regulation of TRAIL levels. Cancer Biology & Therapy 14:12, pages 1158-1166.
Read now

Articles from other publishers (3)

Reyhaneh Moradi Marjaneh, Seyed Mahdi Hassanian, Niloofar Ghobadi, Gordon A. Ferns, Afshin Karimi, Mir Hadi Jazayeri, Mohammadreza Nasiri, Amir Avan & Majid Khazaei. (2018) Targeting the death receptor signaling pathway as a potential therapeutic target in the treatment of colorectal cancer. Journal of Cellular Physiology 233:10, pages 6538-6549.
Crossref
Fabien J. Cousin, Sandrine Jouan-Lanhouet, Nathalie Théret, Catherine Brenner, Elodie Jouan, Gwénaëlle Le Moigne-Muller, Marie-Thérèse Dimanche-Boitrel & Gwénaël Jan. (2016) The probiotic Propionibacterium freudenreichii as a new adjuvant for TRAIL-based therapy in colorectal cancer . Oncotarget 7:6, pages 7161-7178.
Crossref
V O Kaminskyy, O V Surova, T Piskunova, I B Zborovskaya, E M Tchevkina, L Andera & B Zhivotovsky. (2013) Upregulation of c-FLIP-short in response to TRAIL promotes survival of NSCLC cells, which could be suppressed by inhibition of Ca2+/calmodulin signaling. Cell Death & Disease 4:3, pages e522-e522.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.